JP2014166350A5 - - Google Patents

Download PDF

Info

Publication number
JP2014166350A5
JP2014166350A5 JP2014014461A JP2014014461A JP2014166350A5 JP 2014166350 A5 JP2014166350 A5 JP 2014166350A5 JP 2014014461 A JP2014014461 A JP 2014014461A JP 2014014461 A JP2014014461 A JP 2014014461A JP 2014166350 A5 JP2014166350 A5 JP 2014166350A5
Authority
JP
Japan
Prior art keywords
drug
support
dissolution
separation layer
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014014461A
Other languages
Japanese (ja)
Other versions
JP6334181B2 (en
JP2014166350A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2014014461A priority Critical patent/JP6334181B2/en
Priority claimed from JP2014014461A external-priority patent/JP6334181B2/en
Publication of JP2014166350A publication Critical patent/JP2014166350A/en
Publication of JP2014166350A5 publication Critical patent/JP2014166350A5/ja
Application granted granted Critical
Publication of JP6334181B2 publication Critical patent/JP6334181B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (6)

薬剤及び水溶性ポリマーを含む薬剤層と、
前記薬剤層の水溶性ポリマーよりも水溶性が高く設定された水溶性ポリマーを含む溶解分離層と、
持ち手となる支持体とを備え、
前記溶解分離層を介して前記薬剤層と前記支持体とが反対側に接続される、眼に薬剤を投与するための薬剤付き支持体。 A drug layer comprising a drug and a water-soluble polymer;
A dissolution separation layer comprising a water-soluble polymer set to have a higher water solubility than the water-soluble polymer of the drug layer;
With a support to be a handle,
A support with a drug for administering a drug to the eye, wherein the drug layer and the support are connected to the opposite side via the dissolution separation layer. 前記薬剤層の全部または一部と前記溶解分離層の一部とが重なっている請求項１に記載の薬剤付き支持体。   The support with a drug according to claim 1, wherein all or a part of the drug layer and a part of the dissolution / separation layer overlap each other. 前記溶解分離層の一部と前記支持体の一部とが重なっている請求項２に記載の薬剤付き支持体。   The support body with a chemical | medical agent of Claim 2 with which a part of said melt | dissolution separation layer and a part of said support body have overlapped. 前記溶解分離層と前記支持体とが熱圧着または接着されている請求項１〜３のいずれか一項に記載の薬剤付き支持体。   The support body with a medicine according to any one of claims 1 to 3, wherein the dissolution separation layer and the support body are thermocompression-bonded or bonded. 前記溶解分離層の水または生理食塩水に対する平均崩壊時間が６０秒以下である請求項１〜４のいずれか一項に記載の薬剤付き支持体。   The support with a medicine according to any one of claims 1 to 4, wherein an average disintegration time of the dissolution / separation layer with respect to water or physiological saline is 60 seconds or less. 請求項１〜５のいずれか一項に記載の薬剤付き支持体を用いて眼表面に一定量の薬剤を投与する方法。
The method to administer a fixed quantity of chemical | medical agent to the ocular surface using the support body with a chemical | medical agent as described in any one of Claims 1-5.
JP2014014461A 2013-01-29 2014-01-29 Drug-supported substrate with dissolution separation layer Expired - Fee Related JP6334181B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014014461A JP6334181B2 (en) 2013-01-29 2014-01-29 Drug-supported substrate with dissolution separation layer

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013014670 2013-01-29
JP2013014670 2013-01-29
JP2014014461A JP6334181B2 (en) 2013-01-29 2014-01-29 Drug-supported substrate with dissolution separation layer

Publications (3)

Publication Number Publication Date
JP2014166350A JP2014166350A (en) 2014-09-11
JP2014166350A5 true JP2014166350A5 (en) 2017-02-09
JP6334181B2 JP6334181B2 (en) 2018-05-30

Family

ID=51262300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014014461A Expired - Fee Related JP6334181B2 (en) 2013-01-29 2014-01-29 Drug-supported substrate with dissolution separation layer

Country Status (3)

Country Link
JP (1) JP6334181B2 (en)
TW (1) TW201517919A (en)
WO (1) WO2014119587A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017033967A1 (en) * 2015-08-24 2017-03-02 参天製薬株式会社 Ophthalmic film formulation
EP3487480A4 (en) * 2016-07-20 2019-07-24 Ryan, Edwin Eye drop applicator and method
KR102467288B1 (en) * 2020-06-09 2022-11-17 동국대학교 산학협력단 Drug delivery device for conjunctival contact
CN119455236B (en) * 2025-01-08 2025-05-30 湖南省华芯医疗器械有限公司 Drug release balloon, drug release device and endoscope assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200429A (en) * 1981-04-30 1984-10-19 Smith & Nephew Ass Applicator for placing pharmaceutically active agent in contact with moist surface,e.g.,eye
US20020187181A1 (en) * 2001-05-14 2002-12-12 3M Innovative Properties Company System for delivering cosmetics and pharmaceuticals
DE10246900A1 (en) * 2002-10-08 2004-04-22 Horstmann, Michael, Dr. Device for safe dosing of systemic and tropical medication that can be applied to the eye
MX2013001116A (en) * 2010-07-29 2013-06-05 Santen Pharma Co Ltd Drug support body, and method for producing same.

Similar Documents

Publication Publication Date Title
Latta Letter from Dr. Latta to the Secretary of the Central Board of Health, London, affording a view of the rationale and results of his practice in the treatment of cholera by aqueous and saline injections. 1832
BR112015010566A2 (en) methods and devices for the treatment of eye disease in human subjects
WO2015095624A3 (en) Drug mixing and delivery system and method
WO2015165413A8 (en) New stable antibody-drug conjugate, preparation method therefor, and use thereof
JP2015517350A5 (en)
JP2016532516A5 (en)
AR088585A1 (en) A MEDICINAL PRODUCT TO TREAT THE PREVIOUS EYE DISEASE
JP2014166350A5 (en)
JP2019522037A5 (en)
WO2016100949A3 (en) Method and compositions for dissolving or solubilizing therapeutic agents
EP4403220A3 (en) Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
HK1254855A1 (en) Intravenous administration of citrulline during surgery
AR109946A1 (en) ARTIFICIAL PANTS
USD888954S1 (en) Surgery needle for skin treatment device
JP2016533856A5 (en)
WO2013069925A3 (en) Ocular drug delivery system and method for manufacturing microbubbles used therein
RU2015154876A (en) METHOD FOR SURGICAL TREATMENT OF DIABETIC MACULAR Edema WITH VITREOMACULAR TRACTION
CN302012158S (en) cap pin
Sanai Propylthiouracil/thiamazole
Carle Hyaluronic acid
CN302155935S (en) Infusion pump (can be heated)
CN302528095S (en) Disposable Portable Infusion Pump
GB201603364D0 (en) Ultrasonic atomising vibrating micron micro mesh(mmm)disc nicotine drug deliverdevice to be used in the medical nicotine replacement therapy market.
Metyas Zoledronic acid
CN302256472S (en) Activated coagulation time and coagulation rate monitor